Emicizumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Emicizumab and local guidelines before prescribing.

Bispecific antibody

Mechanism

Bispecific antibody mimicking factor VIII.

Uses

Prophylaxis in haemophilia A.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Injection-site reaction, thrombotic microangiopathy with aPCC.

Interactions

Activated prothrombin complex concentrate with caution.

Contraindications and cautions

Hypersensitivity

Monitoring

Bleeding episodes

Pregnancy and breastfeeding

Specialist advice

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Does not need factor VIII activity monitoring; interferes with some coagulation assays.

More from the textbook: uses, cautions and other points
Where it is discussed in the book